• OPEN AN ACCOUNT
Indian Indices
Sensex
74,459.53 308.49
( 0.42%)
Global Indices
Nasdaq
51,732.40 -631.16
(-1.21%)
Dow Jones
7,581.68 -159.71
(-2.06%)
Hang Seng
63,176.05 -1,483.42
(-2.29%)
Nikkei 225
10,722.51 0.44
(0.00%)
Forex
USD-INR
95.22 0.06
(0.06%)
EUR-INR
106.19 0.24
(0.23%)
GBP-INR
127.01 0.44
(0.35%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

Concord Biotech Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543960
INE338H01029
199.4246723
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CONCORDBIO
43.83
13027.86
EPS(TTM)
Face Value()
Div & Yield %
28.41
1
0.61
 

Board of Trident recommends interim dividend
May 20,2026
Trident announced that the Board of Directors of the Company at its meeting held on 19 May 2026, inter alia, have recommended the interim dividend of Rs 0.5 per equity Share (i.e. 50%) , subject to the approval of the shareholders.